Floatz logo

DEXAMETHASONE

Chemotherapy Induced Peripheral Neuropathy

University Hospital, Clermont-FerrandSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Chemotherapy Induced Peripheral Neuropathy cohort.

Asset / SponsorPhaseRating
Omeprazole
Aya Mohamed Sadek Elsaid
Phase 3BB
Inno-206
Mansoura University
Phase 2B
Cyclophosphamide
Mansoura University
Phase 2B
Bortezomib
University Hospital, Clermont-Ferrand
D
PREDNISONE TABLETS
University Hospital, Clermont-Ferrand
D

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →